OSE Immunotherapeutics Enters a Loan Agreement of up to €25 Million with the European Investment...

OSE Immunotherapeutics Enters a Loan Agreement of up to €25 Million with the European Investment Bank

  • This loan will further support the progress and expansion of OSE Immunotherapeutics’ lead clinical development programs in diseases with high unmet medical needs,

  • Divided into three tranches including two tranches of €10 million each and a third tranche of €5 million,

  • Agreement part of the European Investment Bank’s strategy to support biotech companies developing a high-level of expertise in various areas such as OSE’s immunotherapy programs, including its vaccine program against SARS-CoV-2...


021021 Storfund set to offer US$1bn to e
.
Download • 47KB


Medical and Pharma Insider

A Program of FC Global Strategies LLC

383 Corona Street, Suite 589, Denver CO 80218 USA

Tel +1 303 478 4887

Website: www.medicalandpharmainsider.com

Email mail@medicalandpharmainsider.com

MedicalandPharmaInsider- (1).jpg
FC Global Strategies.png

©2021 Medical and Pharma Insider and FC Global Strategies LLC